Showing results (1051-1060 of 2,811) with videos related to

Sort By:
Pageof 282
Expert Opinion on Drug Safety|June 17, 2021
Ibrutinib plus rituximab for the treatment of adult patients with Waldenström's macroglobulinemia: a safety evaluationMagdalini Migkou, Despina Fotiou, Maria Gavriatopoulou, et al.
Expert Opinion on Drug Safety|November 21, 2022
An umbrella review of systematic reviews on contributory factors to medication errors in health-care settingsLina Naseralallah, Derek Stewart, Ruba Azfar Ali, et al.
Expert Opinion on Drug Safety|November 9, 2012
Examining the safety of PPAR agonists - current trends and future prospectsMichele Bortolini, Matthew B Wright, Martin Bopst, et al.
Expert Opinion on Drug Safety|March 14, 2015
Feedback for patients reporting adverse drug reactions; satisfaction and expectationsLeàn Rolfes, Florence van Hunsel, Kees van Grootheest, et al.
Expert Opinion on Drug Safety|July 24, 2020
Rationale and design of a European epidemiological post-authorization safety study (PASS) program: rivaroxaban use in routine clinical practiceLuis Alberto García-Rodríguez, Mari-Ann Wallander, Leif Friberg, et al.
Expert Opinion on Drug Safety|January 4, 2014
Tricyclic antidepressants in pregnancy and puerperiumSalvatore Gentile
Expert Opinion on Drug Safety|January 11, 2014
A systematic review of the safety of probioticsTina Didari, Sara Solki, Shilan Mozaffari, et al.
Expert Opinion on Drug Safety|July 1, 2014
Safety of antipsychotic drugs: focus on therapeutic and adverse effectsFelix-Martin Werner, Rafael Coveñas
Pageof 282